Harvard Kennedy School Harvard University

Search this site

logo
Faculty Research Working Paper Series
F.M. Scherer
Professor of Public Policy and Corporate Management in the Aetna Chair, Emeritus
phone: 617-497-4345
R&D Costs and Productivity in Biopharmaceuticals
Scherer, F.M. "R&D Costs and Productivity in Biopharmaceuticals." HKS Faculty Research Working Paper Series RWP11-046, December 2011.
Abstract
This article characterizes the activities required to launch a new pharmaceutical molecule into the market, summarizes studies that have attempted to pinpoint the research and development costs incurred per approved new molecule, and analyzes the various critiques levied against published R&D cost estimates. It finds that by any reckoning, R&D costs per approved molecule have risen sharply over time, most likely at a rate of approximately 7 percent per year after stripping out the effects of general economic inflation.
Attachment
pdf

 

 


Copyright © 2017 The President and Fellows of Harvard College